This case study underscores the importance of integrated and adaptive care in the treatment of chronic wounds, particularly in patients suffering from autoimmune diseases.
This case study underscores the importance of integrated and adaptive care in the treatment of chronic wounds, particularly in patients suffering from autoimmune diseases.
Key Findings:
The geko device group showed a significantly improved healing rate of 0.56 mm per week compared to 0.31 mm in the control group. Additionally, the average time to wound closure was reduced from 77 days to just 40 days with the use of the geko device.